196 related articles for article (PubMed ID: 35482720)
21. SSTR5‑AS1 functions as a ceRNA to regulate CA2 by sponging miR‑15b‑5p for the development and prognosis of HBV‑related hepatocellular carcinoma.
Xu J; Zhang J; Shan F; Wen J; Wang Y
Mol Med Rep; 2019 Dec; 20(6):5021-5031. PubMed ID: 31638225
[TBL] [Abstract][Full Text] [Related]
22. Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma.
Cao D; Wang Y; Li D; Wang L
Crit Rev Eukaryot Gene Expr; 2019; 29(6):539-549. PubMed ID: 32422009
[TBL] [Abstract][Full Text] [Related]
23. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
[TBL] [Abstract][Full Text] [Related]
24. High glucose regulates ERp29 in hepatocellular carcinoma by LncRNA MEG3-miRNA 483-3p pathway.
Li X; Cheng T; He Y; Zhou S; Wang Y; Zhang K; Yu P
Life Sci; 2019 Sep; 232():116602. PubMed ID: 31251997
[TBL] [Abstract][Full Text] [Related]
25.
Pellegrino R; Castoldi M; Ticconi F; Skawran B; Budczies J; Rose F; Schwab C; Breuhahn K; Neumann UP; Gaisa NT; Loosen SH; Luedde T; Costa IG; Longerich T
Cells; 2022 May; 11(9):. PubMed ID: 35563834
[TBL] [Abstract][Full Text] [Related]
26. The SNHG1-Centered ceRNA Network Regulates Cell Cycle and Is a Potential Prognostic Biomarker for Hepatocellular Carcinoma.
Zhou L; Zhang Q; Deng H; Ou S; Liang T; Zhou J
Tohoku J Exp Med; 2022 Nov; 258(4):265-276. PubMed ID: 36244757
[TBL] [Abstract][Full Text] [Related]
27. Small regulatory polypeptide of amino acid response negatively relates to poor prognosis and controls hepatocellular carcinoma progression via regulating microRNA-5581-3p/human cardiolipin synthase 1.
Yin J; Liu Q; Chen C; Liu W
J Cell Physiol; 2019 Aug; 234(10):17589-17599. PubMed ID: 30825207
[TBL] [Abstract][Full Text] [Related]
28. The competitive endogenous RNA regulatory network reveals potential prognostic biomarkers for overall survival in hepatocellular carcinoma.
Zhang Z; Li J; He T; Ouyang Y; Huang Y; Liu Q; Wang P; Ding J
Cancer Sci; 2019 Sep; 110(9):2905-2923. PubMed ID: 31335995
[TBL] [Abstract][Full Text] [Related]
29. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
Huang DP; Zeng YH; Yuan WQ; Huang XF; Chen SQ; Wang MY; Qiu YJ; Tong GD
Int J Med Sci; 2021; 18(2):335-346. PubMed ID: 33390802
[No Abstract] [Full Text] [Related]
30. lncRNA OSER1-AS1 acts as a ceRNA to promote tumorigenesis in hepatocellular carcinoma by regulating miR-372-3p/Rab23 axis.
Fan J; Zhang J; Huang S; Li P
Biochem Biophys Res Commun; 2020 Jan; 521(1):196-203. PubMed ID: 31635804
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel intermittent hypoxia-related prognostic lncRNA signature and the ceRNA of lncRNA GSEC/miR-873-3p/EGLN3 regulatory axis in lung adenocarcinoma.
Liu P; Zhou L; Chen H; He Y; Li G; Hu K
PeerJ; 2023; 11():e16242. PubMed ID: 37842058
[TBL] [Abstract][Full Text] [Related]
32. lncRNA-AC079061.1/VIPR1 axis may suppress the development of hepatocellular carcinoma: a bioinformatics analysis and experimental validation.
Lin XH; Zhang DY; Liu ZY; Tang WQ; Chen RX; Li DP; Weng S; Dong L
J Transl Med; 2022 Aug; 20(1):379. PubMed ID: 36038907
[TBL] [Abstract][Full Text] [Related]
33. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma.
Chen S; Zhang Y; Ding X; Li W
Front Genet; 2022; 13():838869. PubMed ID: 35386284
[No Abstract] [Full Text] [Related]
34. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
35. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive ceRNA network analysis and experimental studies identify an IGF2-AS/miR-150/IGF2 regulatory axis in colorectal cancer.
Liu B; Liu Y; Zhou M; Yao S; Bian Z; Liu D; Fei B; Yin Y; Huang Z
Pathol Res Pract; 2020 Oct; 216(10):153104. PubMed ID: 32853944
[TBL] [Abstract][Full Text] [Related]
37. Systemic analysis identifying PVT1/DUSP13 axis for microvascular invasion in hepatocellular carcinoma.
Su R; Zhang H; Zhang L; Khan AR; Zhang X; Wang R; Shao C; Wei X; Xu X
Cancer Med; 2023 Apr; 12(7):8937-8955. PubMed ID: 36524545
[TBL] [Abstract][Full Text] [Related]
38. Candidate lncRNA-miRNA-mRNA network in predicting hepatocarcinogenesis with cirrhosis: an integrated bioinformatics analysis.
Zhang R; Jiang YY; Xiao K; Huang XQ; Wang J; Chen SY
J Cancer Res Clin Oncol; 2020 Jan; 146(1):87-96. PubMed ID: 31758243
[TBL] [Abstract][Full Text] [Related]
39. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
